Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARA290 effects on emotional cognition in healthy volunteers
NL-OMON36412Phase 2Active, not recruiting
- Sponsor
- Leiden University
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in major depressive disorder (MDD) comparing ARA290 with Placebo (2 arms). Primary endpoints: Facial emotion recognition accuracy and speed, Positive self-referential memory recall and 3 more. Started Oct 2011; status: active, not recruiting.
02
Drugs
cibinetide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON36412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36412.